Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy.

Ralf Weiskirchen

Journal: Signal transduction and targeted therapy 2023;8(1):339

PMID: 37691051

Free Full Text on Nature Publishing Group View on PubMed

Abstract

Address: Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, Pauwelsstr. 30, D-52074, Aachen, Germany. [email protected].

DOI: 10.1038/s41392-023-01592-4

Link outs

Free resources

Full Text Sources:

https://doi.org/10.1038/s41392-023-01592-4
https://pmc.ncbi.nlm.nih.gov/articles/pmid/3769105...
https://europepmc.org/abstract/MED/37691051

MeSH Terms: Humans, Copper, Inflammation, Macrophages

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.